Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Fellows are selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.

Graham Ogg photo

Professor Graham Ogg is one of 11 University of Oxford biomedical and health scientists elected to the Academy of Medical Sciences Fellowship.

Professor Ogg has led ground-breaking research into COVID-19 immune responses, as well as continuing with his research into the role of human cutaneous immune responses in mechanisms of disease, treatment and vaccination. He is currently collaborating with colleagues in Sri Lanka to compare COVID-19 responses in different populations, to uncover the role of 'background' immunity to virus strains already in circulation. He has also co-led a study demonstrating that individuals with mild COVID-19 had a different pattern of T cell response when compared to those with more severe infection.

Professor Ogg was also the first recipient of the now annual RDM awards for excellent supervision, with members of his team commending him for 'his incredible enthusiasm and optimism', and for always having time to meet people and provide prompt and excellent feedback. 

Professor Ogg said "I am delighted to have received such a prestigious honour, which really reflects a group effort with my terrific team in the MRC Human Immunology Unit."

Many congratulations to Professor Ogg!

Read the full story on the Oxford University website

Similar stories

New Associate Professor appointments announced

Congratulations to Dr Bethan Psaila, Dr Benjamin Fairfax, Dr Hashem Koohy, Dr Andrew Blackford and Dr Oliver Bannard who have all been awarded the title of Associate Professor in recognition of their research achievements, contribution to teaching and contributions to the Medical Sciences Division.

Mechanism behind repair of cancer-inducing mutations discovered

New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.

DNA breakthrough could help identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

New clinical trial for patients affected by blood cancer

Radcliffe Department of Medicine's Professor Adam Mead is leading PROMise, a new clinical trial offering a novel treatment option for patients with a type of blood cancer called myelofibrosis.